Cho Jae-Hyoung, Lee Hye-Chung, Lim Dong-Jun, Kwon Hyuk-Sang, Yoon Kun-Ho
Division of Endocrinology and Metabolism, Department of Internal Medicine, Catholic University of Korea, Kangnam St Mary's Hospital, 505 Banpo-Dong, Seocho-Ku, Seoul, Korea.
J Telemed Telecare. 2009;15(2):77-82. doi: 10.1258/jtt.2008.080412.
A mobile phone with a glucometer integrated into the battery pack (the 'Diabetes Phone') was launched in Korea in 2003. We compared its effect on management of type 2 diabetes to the Internet-based glucose monitoring system (IBGMS), which had been studied previously. We conducted a randomized trial involving 69 patients for three months. Participants were assigned to an Internet group or a phone group. The phone group communicated with medical staff through the mobile phone only. Their glucose-monitoring data were automatically transferred to individual, web-based charts and they received medical recommendations by short message service. The Internet group used the IBGMS. There were no significant differences between the groups at baseline. After three months' intervention, HbA(1c) levels of both groups had decreased significantly, from 7.6% to 6.9% for the Internet group and from 8.3% to 7.1% for the phone group (P < 0.01). Levels of patient satisfaction and adherence to medical advice were similar. Mobile, bidirectional communication between doctors and patients using the diabetes phone was as effective for glucose control as the previously-studied Internet-based monitoring system and it was good for patient satisfaction and adherence.
2003年，一款将血糖仪集成在电池组中的手机（“糖尿病手机”）在韩国推出。我们将其对2型糖尿病管理的效果与之前研究过的基于互联网的血糖监测系统（IBGMS）进行了比较。我们进行了一项为期三个月、涉及69名患者的随机试验。参与者被分配到互联网组或手机组。手机组仅通过手机与医护人员沟通。他们的血糖监测数据会自动传输到个人的基于网络的图表中，并且他们通过短信服务接收医疗建议。互联网组使用IBGMS。两组在基线时没有显著差异。经过三个月的干预后，两组的糖化血红蛋白（HbA₁c）水平均显著下降，互联网组从7.6%降至6.9%，手机组从8.3%降至7.1%（P<0.01）。患者满意度和对医疗建议的依从性水平相似。使用糖尿病手机在医生和患者之间进行的移动双向通信在血糖控制方面与之前研究的基于互联网的监测系统一样有效，并且对患者满意度和依从性也有好处。
